As a consequence of hyperglycemia, vehicle‐treated diabetic rats had marked glucosuria and polyuria; and while glycemia was substantially improved by dapagliflozin, SGLT2 inhibition led to glucosuria and polyuria that were similar to those receiving vehicle only. Here, SLC5A2 is linked to Hyperglycemia.